Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Gadoteridol is a gadolinium-based MRI contrast agent.1,2 It enhances the visibility of intraparenchymal and meningeal tumors in an orthotopic rat model of brain cancer when administered at a dose of 0.25 mmol/kg.1 In vitro labeling of murine mesenchymal stem cells (MSCs) with gadoteridol and subsequent injection into mice has been used to track their migration to spinal cord injury lesions in vivo.2 Formulations containing gadoteridol have been used to visualize intra- and extracranial lesions in the head, neck, and spine.
WARNING This product is not for human or veterinary use.
1. Gd HP-
2. Successful in vivo MRI tracking of MSCs labeled with gadoteridol in a spinal cord Injury experimental model. Exp. Neurol. 282, 66-77 (2016).